Logo Image
|Articles|September 23, 2014

Clinical Trial Experts Respond to Negative Toronto Sun Article

President and Co-founder of Canadian CRO Scimega Research, Denise Deakin, addresses last week's article published in the Toronto Star

In this blog

, President and Co-founder of Canadian CRO Scimega Research, Denise Deakin addresses last week's article published in the Toronto Star regarding lax oversight of clinical trials in Canada. Ms. Deakin outlines the seriousness of the charges, however, believes that the public should view this information in the proper context and "be made aware of what percentage this represents out of the entire clinical research spectrum across the country."

Related to this article

View more
© C Davids/peopleimages.com - © C Davids/peopleimages.com - stock.adobe.com
What "Patient Voice" Actually Requires: Beyond the Buzzword
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.
Read more
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
Read more